Merck Sharp & Dohme Farmaceutica logo
Merck Sharp & Dohme Farmaceutica6 days ago

Senior Specialist, Financial Analyst (Hybrid - NJ or PA)

$106,200–$167,200 year

Hybrid · Rahway, New Jersey, United States or West Point, Pennsylvania, United States

Type
Full Time
Level
Senior Level
Education
Bachelors Degree
Company size
Unknown

Job Summary

Senior Specialist, Financial Analyst (Hybrid - NJ or PA) provides financial planning, forecasting, and analytical support for Global Clinical Supplies within R&D. Responsible for modeling spend related to freight, warehousing, distribution, external packaging and labeling, shipping supplies, and staff resources; develops Budget and Long Range Operating Plan, quarterly forecasts, and monthly close activities; contributes to ad hoc analyses and client presentations; supports cross-functional partnerships with Finance, Supply Chain, Procurement, and Clinical Development. Requires at least 2 years of finance/operations experience, a BA/BS, and proficiency in SAP, BPC, Excel, and Power BI. Travel is limited. Location options include Rahway, NJ and West Point, PA with Hybrid work arrangement.

Required Qualifications

  • Minimum of 2 years of operations or Finance experience
  • Minimum of a B.A./B.S. in Business, Finance, Science or Engineering
  • Strong computer skills including SAP, BPC, Excel and PowerPoint
  • Experience and/or interest in building and maintaining Power BI visuals and dashboards
  • Demonstrated ability to influence and build client relationships
  • Excellent interpersonal and communication skills
  • Strong financial acumen
  • Proactive problem-solving and results orientation
  • Ability to work in a challenging environment
  • Travel up to 10%
Sorce

Apply with one swipe on Sorce. We auto-fill applications and apply on your behalf — no cover letters, no 40-minute forms.

Hiring someone like this?

Get your role in front of qualified candidates on Sorce.

Get started

$106k – $167k / yr

Senior Specialist, Financial Analyst (Hybrid - NJ or PA) · Merck Sharp & Dohme Farmaceutica

Apply on Sorce